HMN 2025: How the hormone FGF21 can reverse fatty liver illness

A pioneering analysis study published right this moment in Cell Metabolism particulars how the hormone FGF21 (fibroblast progress issue 21) can reverse the results of fatty liver illness in mice. The hormone works primarily by signaling the mind to enhance liver perform.

University of Oklahoma researcher Matthew Potthoff, Ph.D., is the lead creator of the research, which offers worthwhile perception concerning the mechanism of motion of the hormone, which is a goal for a brand new class of extremely anticipated medicine which are in Phase 3 scientific trials.

“Fatty liver illness, or MASLD (metabolic dysfunction-associated steatotic liver illness), is a buildup of fats within the liver. It can progress to MASH (metabolic dysfunction-associated steatohepatitis) throughout which fibrosis—and finally, cirrhosis—can happen. MASLD is changing into a really large drawback within the United States, affecting 40% of individuals worldwide, and there may be at present just one therapy permitted by the Food and Drug Administration to deal with MASH.

“A brand new class of medicine, primarily based on FGF21 signaling, is displaying good therapeutic advantages in scientific trials, however till now, the mechanism for a way they work has been unclear,” mentioned Potthoff, a professor of biochemistry and physiology on the University of Oklahoma College of Medicine and deputy director of OU Health Harold Hamm Diabetes Center.

The study’s outcomes demonstrated that FGF21 was efficient at inflicting signaling within the model species that modified the liver’s metabolism. In doing so, the liver’s fats was lowered and the fibrosis was reversed. The hormone additionally despatched a separate sign on to the liver, particularly to decrease ldl cholesterol.

“It’s a suggestions loop where the hormone sends a sign to the mind, and the mind modifications nerve exercise to the liver to guard it,” Potthoff mentioned. “The majority of the impact comes from the sign to the mind versus signaling the liver immediately, however collectively, the 2 alerts are highly effective of their capability to manage the several types of lipids within the liver.”

Similar to the household of weight-loss medicine referred to as GLP-1s (glucagon-like peptide 1), which assist regulate blood sugar ranges and urge for food, FGF21 acts on the mind to manage metabolism. In addition, each are hormones produced from peripheral tissues—GLP-1 from the gut and FGF21 from the liver—and each work by sending a sign to the mind.

“It is fascinating that this metabolic hormone/drug works primarily by signaling to the mind as a substitute of to the liver immediately, on this case,” he mentioned. “FGF21 is kind of highly effective as a result of it not solely led to a discount of fats, nevertheless it additionally mediated the reversal of fibrosis, which is the pathological a part of the illness, and it did so whereas the mice had been nonetheless consuming a weight loss program that will trigger the illness.

“Now, we not solely perceive how the hormone works, however it could information us in creating much more focused therapies sooner or later.”